Live·Verified funding discovery · 2026.2

874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640

△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA

Ratings

Eternal Search

Heroes

People whose work, funding, scientific leadership, and multiplier effects have shaped the longevity field.

Every score here rates one thing: longevity commitment. The role tags — scientist, investor, founder, and the rest — describe what a person does. We do not compute a separate rating for each tag.

Scoring AI engine · v0.9.0

RolesAll clinician communicator entrepreneur investor operator philanthropist populariser scientist self-experimenter

ThemesAll Destination Meta View Path Risk View Timeline

SortOverall Recently updated Future vision Scientific impact Capital deployed Strategic taste Field creation Bravery and conviction Multiplier effect

#ScoreHeroDimensionsScored

Emil Kendziorrav0.4.0

Kendziorra helped move biostasis from fringe talk into actual institutions and research roadmaps. The science is still speculative; the operator work is the real signal.

entrepreneurscientistself-experimenter

Bryan Johnsonv0.4.0

Johnson made longevity louder by turning his own protocol into media, a Don’t Die campaign, and an Rx platform. The hard evidence for field-building or scientific impact is thin.

self-experimenterpopulariserentrepreneur

Christian Angermayerv0.6.0

Angermayer’s impact is publicity, not proven geroscience. He helped drag longevity-adjacent human enhancement into public markets, sports spectacle, and telehealth. Messy, but visible.

entrepreneurinvestorself-experimenter

Omri Droryv0.4.0

Drory helped frame longevity as techbio infrastructure work, not wellness theater: measure biology better, then pursue reprogramming, regeneration, and replacement. Evidence is thin; call this a signal, not proven field impact.

investorentrepreneurself-experimenter

Derya Unutmazv0.4.0

Unutmaz’s longevity impact is real but narrow: he studies how immunity changes with age, from T-cell regulation to lifespan immune maps. No evidence here for field-building or capital deployment.

scientistself-experimenter

Sam Altmanv0.4.0

No public longevity impact is supported here. The only cited paper is by Soya S Sam on an HIV assay, not Sam Altman, so crediting Altman would be spreadsheet cosplay.

investorself-experimenter